Although this may seem initially counter-intuitive, precedence for increased apoptotic priming, correlating with high anti-apoptotic BCL-2 levels, is evident in various cancers (Certo et al., 2006; Singh et al., 2019). The gene discussed is BCL2; the disease is cancer.